Professor James Larkin will be joining us in July for our next On The Spot webinar.

Watch this short video on the key topics he will be covering later this year:

1. Long-term follow up data for the Immunotherapy trials first introduced in 2013/2014
2. New drug called Relatlimab
3. Adjuvant Pembrolizumab for stage II melanoma patients
4. Cellular therapy